Novel biomarkers in Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is an alarming gynaecological endocrine disorder affects women of reproductive age. Hyperandrogenism contributes for a cluster of cardio-metabolic risk factors characterized by reproductive dysfunction, polycystic ovaries, anovulation, and cosmetic dysfunctions. Alth...

Full description

Saved in:
Bibliographic Details
Published in:Research journal of pharmacy and technology 2024-01, Vol.17 (1), p.439-442
Main Authors: Kaur Chahal, Simerjeet, Kabra, Atul, Kaur Sodhi, Rupinder
Format: Article
Language:English
Subjects:
Androgens
Biomarkers
Chromosomes
Cytochrome
Enzymes
Estrogens
Follicles
Gene expression
Insulin resistance
Kinases
Metabolism
MicroRNAs
Nervous system
Ovaries
Polycystic ovary syndrome
Proteins
Reproductive system
Testosterone
Womens health
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Polycystic ovary syndrome (PCOS) is an alarming gynaecological endocrine disorder affects women of reproductive age. Hyperandrogenism contributes for a cluster of cardio-metabolic risk factors characterized by reproductive dysfunction, polycystic ovaries, anovulation, and cosmetic dysfunctions. Although during the past decades, substantial research efforts tried to uncover the exact aetiology and pathogenesis of PCOS but owing to the complex etiology, the patho-physiological mechanisms of PCOS remains in doubt. To develop potential and highly efficient therapeutic strategies, there are many proteins which can act as potential biomarkers for PCOS. These biomarker proteins and enzymes may involve in the early detection and handling of this condition and mitigate the risk of long-term problems.
ISSN:0974-3618
0974-360X
0974-306X
DOI:10.52711/0974-360X.2024.00069